CD8A and neoplasm: To test the connectivity of inflammation and CD8 T cell infiltration across other oncolytic virotherapies, we treated tumor bearing mice with Reovirus or replication-defective Adenovirus, both of which have been extensively characterized in preclinical and clinical settings28,29,42–44.